Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Omada Health, Inc. (OMDA : NSDQ)
 
 • Company Description   
Omada Health Inc. provides a range of virtual care programs principally in the United States. The company offers cardiometabolic programs for prediabetes, diabetes and hypertension; a physical therapy program to address musculoskeletal conditions other support programs. Omada Health Inc. is based in San Francisco, California.

Number of Employees: 916

 
 • Price / Volume Information   
Yesterday's Closing Price: $22.77 Daily Weekly Monthly
20 Day Moving Average: 1,042,995 shares
Shares Outstanding: 61.22 (millions)
Market Capitalization: $1,393.90 (millions)
Beta: 1.86
52 Week High: $26.89
52 Week Low: $10.28
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -8.88% -8.48%
12 Week 31.39% 28.59%
Year To Date 44.30% 27.97%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
611 Gateway Blvd Suite 120
-
South San Francisco,CA 94080
USA		 ph: 888-987-8337
fax: -		 ir@omadahealth.com http://www.omadahealth.com
 
 • General Corporate Information   
Officers
Sean Duffy - Chief Executive Officer and Director
Steve Cook - Chief Financial Officer
Jeryl Hilleman - Director
Anne Beal - Director
Trevor Fetter - Director

Peer Information
Omada Health, Inc. (CHCR)
Omada Health, Inc. (ESRX)
Omada Health, Inc. (MYDP)
Omada Health, Inc. (COR)
Omada Health, Inc. (GBCS)
Omada Health, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 68170A108
SIC: 8000
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/26
Next Expected EPS Date: 11/05/26
Share - Related Items
Shares Outstanding: 61.22
Most Recent Split Date: (:1)
Beta: 1.86
Market Capitalization: $1,393.90 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.01 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.09 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/05/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 267.88
Trailing 12 Months: 284.62
PEG Ratio: -
Price Ratios
Price/Book: 5.36
Price/Cash Flow: -
Price / Sales: 4.50
EPS Growth
vs. Year Ago Period: 136.36%
vs. Previous Quarter: 260.00%
Sales Growth
vs. Year Ago Period: 43.12%
vs. Previous Quarter: 12.54%
ROE
06/30/26 - 2.60
03/31/26 - -1.82
12/31/25 - -6.44
ROA
06/30/26 - 1.98
03/31/26 - -1.36
12/31/25 - -4.75
Current Ratio
06/30/26 - 3.91
03/31/26 - 3.92
12/31/25 - 3.60
Quick Ratio
06/30/26 - 3.85
03/31/26 - 3.87
12/31/25 - 3.54
Operating Margin
06/30/26 - 1.96
03/31/26 - -1.44
12/31/25 - -4.09
Net Margin
06/30/26 - 1.39
03/31/26 - -2.22
12/31/25 - -4.91
Pre-Tax Margin
06/30/26 - 1.39
03/31/26 - -2.22
12/31/25 - -4.91
Book Value
06/30/26 - 4.25
03/31/26 - 3.94
12/31/25 - 3.97
Inventory Turnover
06/30/26 - 25.29
03/31/26 - 25.60
12/31/25 - 32.16
Debt-to-Equity
06/30/26 - 0.00
03/31/26 - 0.00
12/31/25 - 0.00
Debt-to-Capital
06/30/26 - 0.00
03/31/26 - 0.00
12/31/25 - 0.00
 

Powered by Zacks Investment Research ©